Caption
Researcher in a laboratory
Funding boost for promising treatment
Date
Research news
Date
Through the Parkinson’s Virtual Biotech, we’re investing £1.1m to co-fund a study looking at whether a cough medicine, ambroxol, has the potential to slow the progression of Parkinson’s.
Date
Results from a clinical trial looking at reducing iron levels in the brain have shown no benefit for unmedicated people with Parkinson’s.
Date
Light therapy as a potential treatment for Parkinson’s hits the headlines. We take a deeper look at what we know about it so far.
Date
Back in the summer, we called upon the Parkinson’s community to take part in 5 clinical trials that were at a potential risk of closing. Thanks to you, we had an incredible response and want to keep up the momentum of encouraging people to take part in research.
Date
The biotech company NRG Therapeutics has received a large investment to continue its drug development project into life-changing new treatments.
Date
An international clinical trial looking at using stem cells to treat Parkinson’s has been granted approval to go ahead initially in Sweden.
Date
We’re investing £2m in Enterin’s phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson’s dementia.
Date
Over the last 2 years, Vivifi Biotech has made progress towards a trial that aims to overcome the challenges of the last trial. Now, it’s starting work on the final phase of planning.
Date
A study following Scottish international rugby players shows they are more likely to develop neurodegenerative conditions compared to the general public.
Date
A project involving Parkinson’s UK, shows promise for using artificial intelligence to identify Parkinson’s in brains donated to our Brain Bank.